Почетна › Многи мијелом › Misuri
Kliničke studije za Многи мијелом u državi Misuri
27 studija za Многи мијелом traži učesnike na lokacijama u državi Misuri.
Gradovi u državi Misuri
Zvanični tekst studije (na engleskom)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Belton
- MIVA Medical, Independence
- Kansas City VA Medical Center, Kansas City
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06152575A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Washington University School of Medicine in St. Louis, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07393282A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- Washington University School Of Medicine, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07589634A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Washington University School Of Medicine, St Louis
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT05201781A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Washington University School Of Medicine, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04634552A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Washington University/Siteman Cancer Center, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07284758Collection of Tissue Samples for Cancer Research
- Washington University - St. Louis, St Louis
Тражи се учесникОпсервациона студија
2 Months · Оба пола · Ажурирано 27. 10. 2026. · NCT00900198A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT04973605A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
- Research Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 21. 10. 2026. · NCT07735637A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Research Site, St Louis
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07681596Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07200102Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07200089A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06980480An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Washington University School of Medicine, St Louis
Тражи се учесник
Узраст од 18 до 99 · Оба пола · Ажурирано 8. 10. 2026. · NCT07226934Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06297226A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
- Research Site, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT07073547A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
- GSK Investigational Site, Bridgeton
- GSK Investigational Site, Springfield
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT07227311Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- и још 19
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT04566328Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Research Site, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT07764978Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT06483100Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Washington University School of Medicine, St Louis
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06340646Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT06185751Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- и још 3
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- и још 21
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 6. 2026. · NCT05561387Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Washington University /ID# 266972, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 5. 2026. · NCT06896916Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- Saint Louis University, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 4. 2026. · NCT03823534Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 11. 3. 2026. · NCT06623630Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.